Related Experiment Video
Updated: Jun 14, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Adoption of the OMOP CDM for Cancer Research using Real-world Data: Current Status and Opportunities
Liwei Wang1, Andrew Wen1, Sunyang Fu1
1McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, TX, USA.
This review examines how the Observational Medical Outcomes Partnership (OMOP) common data model (CDM) supports cancer research. It highlights current research, challenges, and opportunities for advancing cancer studies using the OMOP CDM ecosystem.
Area of Science:
- Health Informatics
- Cancer Research
- Observational Data Analysis
Background:
- The Observational Medical Outcomes Partnership (OMOP) common data model (CDM) facilitates large-scale cancer research through distributed network analysis.
- The OHDSI community maintains the OMOP CDM, supporting a growing number of cancer research studies.
Purpose of the Study:
- To comprehensively review the adoption of the OMOP CDM for cancer research.
- To provide insights into leveraging the OMOP CDM ecosystem for advancing cancer research.
Main Methods:
- Literature search of published articles on OMOP CDM and cancer research (January 2010 - December 2023).
- Categorization of studies into clinically focused data analysis and infrastructure development themes.
- Development of a charting form for data extraction and analysis.
Main Results:
- 50 unique articles were included in the review.
- 30 articles focused on data analysis, and 23 on infrastructure development, with 3 overlapping.
- The review maps the scope and topics of existing research within the OMOP CDM cancer research domain.
Conclusions:
- Identified challenges and opportunities in data quality, advanced analytics, NLP for phenotypic data, and multisite evaluation.
- Highlights the current status of research efforts to enhance the OMOP CDM ecosystem for cancer research.
- Provides a foundation for future research directions in leveraging OMOP CDM for cancer studies.
More Related Videos
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
08:55Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Related Concept Videos
Cancer Survival Analysis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...